Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.22
Delayed Data
As of 3:59pm ET
 +0.18 / +2.98%
Today’s Change
4.60
Today|||52-Week Range
11.72
+4.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues4.7M2.3M2.8M2.7M
 
 
 
 
 
Depreciation And Amortization218.0K256.0K288.0K288.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses15.1M15.4M17.3M16.0M
 
 
 
 
 
Research And Development10.6M10.0M11.3M10.3M
 
 
 
 
 
Total Operating Expenses15.3M15.7M17.6M16.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-13.4M-14.9M-13.6M
 
 
 
 
 
Extraordinary Credit6.0M0.000.000.00
 
 
Extraordinary Charge0.00-1.9M-700.0K-700.0K
 
 
 
 
Interest Expense On Debt800.0K1.3M1.2M1.2M
 
 
 
 
 
Other Expenses-34.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.4M-16.4M-16.6M-15.4M
 
 
 
 
 
Income Taxes-1.8M0.000.000.00
 
 
Minority Interest-15.0K0.000.000.00
 
 
Net Income-7.2M-16.4M-16.6M-15.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.1M70.2M70.2M70.3M
 
 
 
 
 
Shares To Calculate EPS Diluted70.1M70.2M70.2M70.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.23-$0.24-$0.22
 
 
 
 
 
EPS Diluted-$0.10-$0.23-$0.24-$0.22